■ As Head of Marketing, reporting to Tabuk Country Head, I spearheaded strategic marketing initiatives for a diverse portfolio, achieving a total revenue of more than (350 million EGP) with a significant 14% year-on-year growth rate. Notably.■ I led product campaigns that yielded impressive results, including a 43% growth (68 million EGP) for Triaxone, a 27% growth (28 million EGP) for Rapidus, and a 37% growth (33 million EGP) for Foxime. ■ Develop, implement and evaluate the brand strategy (existing (Divido) and new products (Therazolide) including the marketing campaigns, events, promotional tools/mix, etc., to achieve the qualitative and quantitative objectives.■ Led the development and execution of fully integrated Tabuk Marketing plans and the related marketing activities/programs (TIP - Click to Clinic) to support the short, medium- and long-term business qualitative and quantitative objectives. This is done cross-functionally with the relevant stakeholders at the corporate and country levels.

■ I played a pivotal role in driving the success of a wide range of products, including Ketofan with a 22% growth (139 million EGP) and Neurovit with a 72% growth (332 million EGP) in 2020. I led strategic marketing initiatives that resulted in remarkable brand growth and market presence for both products. My responsibilities included overseeing budget allocation for direct promotions and ensuring that key performance indicators such as market share, growth, and brand tracking were consistently met. I was proactive in implementing corrective measures when necessary and fostered effective cross-departmental collaboration to align with brand-related plans and objectives, all while ensuring timelines were met.■ I excel in overseeing teams (14 members), managing budgets (800 million EGP), and ensuring long-term brand growth. Additionally, I lead cross-functional collaborations to achieve established objectives.

■ Guiding the Marketing teams in the construction and implementation of launch plans to ensure that all pre-launch, launch & post-launch activities are in place (Ultramox Launch 2019) (2023 Sales Revenue 26 million EGP)■ Coordinating with the Commercial Excellence team to ensure the optimum placing of launches within the promotional grid/company and construct incentive schemes that support maximum launch performance (Rani-F Launch 2021) ( 2023 Sales Revenue 310 million EGP)■ Prepare annual forecast for launches (in coordination with the Marketing teams/company) Maximize launch values through challenging Marketing teams / Companies on sales forecast of annual launches (V- Gone Launch 2020) (2023 Sales Revenue 11 million EGP)■ Liaise between Scientific Offices and Sites to ensure on-time delivery of launching goods and optimum distribution (Ticanase Plus launch date 2020) (2023 Sales Revenue 23 million EGP)■ Managing participation in major local conferences cross-companies to achieve maximum impact with optimum resources (Levotavin Launch 2020) (2023 Sales Revenue 42 million EGP)

■ During my nearly 10-year tenure at Hikma, I played a pivotal role in elevating the company's rank from 44th to 9th in the Egyptian market. I managed a team of 4 Product Managers and directed all marketing, advertising, and promotional activities. Through strategic market research and analysis of customer and competitor information, I developed and implemented effective marketing plans and projects. My efforts drove significant revenue growth from 120 million EGP in 2008 to 1.82 billion EGP in 2018. Key achievements include: ■ Lyrolin: Grew sales from Day zero at launch in 2012 to 532 million EGP in 2018. ■ Feburic: from Day zero at launch in 2013 to 68 million EGP in 2018. ■ Doxirazol: From day zero at launch in 2014 to 24 million EGP in 2018. ■ Tavacin: Boosted sales from 9 million EGP in 2008 to 100 million EGP in 2018, achieving market leadership. ■ Pepzol: Elevated sales from 9 million EGP in 2008 to 92 million EGP in 2018. ■ (123): Enhanced sales from 6 million EGP in 2008 to 61 million EGP in 2018. ■ Zithrokan: Increased sales from 9 million EGP in 2008 to 68 million EGP in 2018■ These results reflect a strong marketing presence and effective strategy implementation.■ I managed the productivity of marketing plans and projects, monitored and reported on all marketing activities and results, and determined and managed the marketing budget to ensure activities were delivered within the agreed budget.

■ Responsible for providing the sales team with the necessary technical expertise . This involves printed promotional material, product training, and relevant clinical papers.■ Responsible for reviewing product data to ensure that field force is kept up to date on new developments regarding the companies or competitors.■ Act as point of reference for all product related enquiries and work collaboratively with colleagues in Clinical Research and Regulatory to address any issues that may arise.■ Close liaison with the field force to assess the response to and suitability of current promotional material and to ensure that the printed promotional material is being used optimally.■ Development of the annual marketing plan and for controlling advertising, promotion and sales aids in accordance with the annual marketing plan.■ Responsible for preparing product forecasts, and constantly monitoring inventory levels held at warehouses including liaison with production (locally and globally) to ensure supply timelines. ↓■ Areas of experts: Alimentary & Metabolism Anti-Infective